BACE2: A promising neuroprotective candidate for Alzheimer’s disease

Manuscript Number: 

22-0867R1

Author(s): 
Nagaendran Kandiah, Kah-Leong Lim, Dean Nizetic, Yee Jie Yeap

Disclosures

Nagaendran Kandiah

  • Consulting Fees:
    Scientific Advisor for Neuroglee Therapeutics, Neurowyzr and AllEights
    Lecture Fees:
    Received lecture fees from Schwabe, Danone and Eisai Pharmaceuticals
    Grants
    • Agency: 
      MiRXES
      Dates: 
      2022

Kah-Leong Lim

  • Nothing to Disclose

Dean Nizetic

  • Nothing to Disclose

Yee Jie Yeap

  • Nothing to Disclose